Short Interest in Hologic Declines By 12.9% (HOLX)
Hologic (NASDAQ:HOLX) was the recipient of a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 12,480,861 shares, a decline of 12.9% from the July 31st total of 14,332,831 shares, American Banking & Market News reports. Based on an average daily trading volume, of 1,421,620 shares, the short-interest ratio is currently 8.8 days. Currently, 4.5% of the company’s stock are short sold.
HOLX has been the subject of a number of recent research reports. Analysts at Barrington Research downgraded shares of Hologic from an “outperform” rating to a “market perform” rating in a research note on Tuesday, August 5th. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Hologic in a research note on Thursday, July 31st. They now have a $31.00 price target on the stock, up previously from $28.00. Finally, analysts at SunTrust reiterated a “r” rating on shares of Hologic in a research note on Thursday, July 31st. They now have a $18.00 price target on the stock, up previously from $15.00. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $24.40.
Shares of Hologic (NASDAQ:HOLX) opened at 25.295 on Wednesday. Hologic has a 1-year low of $19.25 and a 1-year high of $26.75. The stock has a 50-day moving average of $25.44 and a 200-day moving average of $23.6. The company’s market cap is $7.026 billion.
Hologic (NASDAQ:HOLX) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.37 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.34 by $0.03. The company had revenue of $632.60 million for the quarter, compared to the consensus estimate of $621.89 million. During the same quarter last year, the company posted $0.38 earnings per share. Hologic’s revenue was up 1.0% compared to the same quarter last year. On average, analysts predict that Hologic will post $1.44 earnings per share for the current fiscal year.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.